Marco Zurlo

Verona, 37134, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

The Evolving Role of Eosinophils in Eosinophilic Esophagitis: Mechanisms, Crosstalk, and Therapeutic Perspectives.

The Evolving Role of Eosinophils in Eosinophilic Esophagitis: Mechanisms, Crosstalk, and Therapeutic Perspectives.

Journal: Cells

Published: May 21, 2026

Safety of anti-IL-5 compounds for the treatment of eosinophilic asthma with a focus on special populations.

Safety of anti-IL-5 compounds for the treatment of eosinophilic asthma with a focus on special populations.

Journal: Expert opinion on drug safety

Published: May 11, 2026

Upper and lower airways response to tezepelumab in asthma patients with / without comorbid nasal polyposis: a 6-months reallife perspective.

Upper and lower airways response to tezepelumab in asthma patients with / without comorbid nasal polyposis: a 6-months reallife perspective.

Journal: Rhinology

Published: January 12, 2026

Upper and lower airways response to tezepelumab in asthma patients with / without comorbid nasal polyposis: a 6-months reallife perspective.

Upper and lower airways response to tezepelumab in asthma patients with / without comorbid nasal polyposis: a 6-months reallife perspective.

Journal: Rhinology

Published: January 12, 2026

Trends of T2 and Non-T2 Cytokines During Mepolizumab Treatment in Different Asthma Patient Subgroups.

Trends of T2 and Non-T2 Cytokines During Mepolizumab Treatment in Different Asthma Patient Subgroups.

Journal: Biomedicines

Published: December 31, 2025

Traditional biomarkers and clinical hallmarks in the frame of epithelial driven airways inflammation.

Traditional biomarkers and clinical hallmarks in the frame of epithelial driven airways inflammation.

Journal: Expert review of respiratory medicine

Published: December 13, 2025

When hypereosinophilia occurs during dupilumab therapy: evidence-based strategies for clinical management in respiratory indications.

When hypereosinophilia occurs during dupilumab therapy: evidence-based strategies for clinical management in respiratory indications.

Journal: Expert review of respiratory medicine

Published: December 13, 2025

Development and implementation of Phleos, a web-based tool for the data collection on Hypereosinophilic syndrome: the Italian Network on HES (INHES) study protocol.

Development and implementation of Phleos, a web-based tool for the data collection on Hypereosinophilic syndrome: the Italian Network on HES (INHES) study protocol.

Journal: Frontiers in immunology

Published: May 31, 2025

ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up.

ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up.

Journal: Respiratory medicine

Published: March 13, 2025

Extracellular Vesicles in Asthma: Intercellular Cross-Talk in TH2 Inflammation.

Extracellular Vesicles in Asthma: Intercellular Cross-Talk in TH2 Inflammation.

Journal: Cells

Published: February 19, 2025

Frequency of Euroglyphus maynei sensitization in respiratory allergies: a real-life study with bioinformatic analysis and geographical exploration of allergen prevalence.

Frequency of Euroglyphus maynei sensitization in respiratory allergies: a real-life study with bioinformatic analysis and geographical exploration of allergen prevalence.

Journal: Allergologia et immunopathologia

Published: February 08, 2024

Safety of isotreinoin treatment in peanut and soy allergy.

Safety of isotreinoin treatment in peanut and soy allergy.

Journal: Postepy dermatologii i alergologii

Published: November 07, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026